Global Respiratory Care Devices Market: Trends, Growth, Key Drivers, and Forecast 2025–2033

Key Market Drivers in the Respiratory Care Devices Market

Increasing Incidence of Respiratory Disorders

The rising incidence of respiratory disorders such as asthma, COPD, and sleep apnea is one of the major growth drivers in this segment. Air pollution, smoking, and occupational hazards are some of the major contributors to the increasing burden of these conditions. Moreover, the increasing elderly population is more susceptible to respiratory disorders due to a decline in lung function. This increase in respiratory illness creates a higher demand for testing, treating, and monitoring technologies. Globally, governments and health care organizations insist on timely diagnosis and successful management; this fuel more market progression. The World Health Organization suggests that CRD accounts for 4.1 million deaths annually.

Technology Enhancement

Respiratory care equipment innovations, portable, as well as smarter, now change the face of patient treatment. Modern devices incorporate wireless connectivity, remote monitoring, and artificial intelligence for precise data analysis and treatment personalization. For example, smart inhalers and wearable oxygen devices improve convenience and compliance. These advancements cater to the increasing preference for home healthcare, boosting the adoption of these devices. Continuous R&D investments are expected to unlock further technological breakthroughs, propelling market expansion. In January 2024, IMVARIA Inc. received FDA approval and CPT billing codes for Fibresolve, an AI-based digital biomarker solution for non-invasive lung fibrosis diagnosis. This allows for formal billing and facilitates integration into healthcare systems.

Increasing Awareness and Healthcare Spending

Awareness programs regarding respiratory health and preventive care are driving the adoption of respiratory care devices. Governments and NGOs are encouraging screening programs and education campaigns that emphasize the need for early management of respiratory disorders. At the same time, increasing healthcare costs in developing countries increase access to respiratory devices. Enhanced healthcare infrastructure and reimbursement policies for respiratory therapies make these devices more accessible, thus leading to substantial growth in the market. April 2024, Royal Philips is setting up a new R&D centre in Maharashtra's Healthcare Innovation Centre. This marks India's growing significance in global healthcare innovation. The facility, to be operational in two years, will focus on Sleep & Respiratory Care, Precision Diagnosis, Image Guided Therapy, and Monitoring.

United States Respiratory Care Devices Market

The United States dominates North America's breathing devices market, with a high prevalence of chronic respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea. The aging population and rising incidence of lifestyle-related disorders are also contributing to increased demand. Advanced healthcare infrastructure and strong government support for innovation further bolster the market. Leading medical device companies and the adoption of state-of-the-art technologies like portable oxygen concentrators and non-invasive ventilators, among others, have been the reasons for the strong presence of the U.S. in the global market for respiratory care devices. React Health's acquisition of the Respiratory line of Invacare in February 2023 further consolidated its market position, expanded its portfolio of products, and enabled it to reach a more extensive customer base.

Germany Respiratory Care Device Market

Germany is one of the major markets for respiratory care devices in Europe, driven by its well-developed healthcare system and high prevalence of respiratory diseases like COPD and lung infections. The aging population in Germany creates a higher demand for oxygen therapy and ventilatory support devices. Germany is also a hub for innovation in medical technology, encouraging the development of advanced respiratory devices such as high-flow nasal cannulas and portable ventilators. Essential government healthcare programs and emphasis on better patient outcomes make Germany the market leader in the European breathing device market. For example, according to the NIHR, the number of COPD patients in Germany was estimated to be around 2.7 million in 2019. Thus, a huge patient base is likely to raise demand for therapeutic respiratory devices and promote the market in Germany.

China Respiratory Care Device Market

Due to rising air pollution and a higher prevalence of respiratory diseases like asthma and bronchitis, the market in China is growing at a high rate. Its aging population and high smoking rates add to the demand for nebulizers, ventilators, and CPAP machines. Government initiatives to improve access to healthcare and infrastructure are driving the adoption of advanced respiratory technologies. With growing awareness about respiratory health and local manufacturing of cost-effective devices, China is poised to be one of the leading contributors to the Asia-Pacific respiratory care devices market.  In November 2022, the Bolivian government selected CANTA oxygen concentrators to supply La Paz, the world's highest capital city. This selection was based on the quality and reliability of the CANTA oxygen concentrators. Canta Medical is a Chinese manufacturer and supplier of respiratory apparatus, oxygen concentrators, & hyperbaric oxygen chambers.

Brazil Respiratory Care Device Market

Brazil is one of the major markets for respiratory care devices in Latin America due to the growing prevalence of chronic respiratory diseases and infections like tuberculosis. Urbanization and industrial pollution aggravate respiratory health issues, leading to a growing demand for better treatment options. The expanding healthcare sector in Brazil, coupled with the government's initiatives to enhance access to medical devices, is driving growth in the market. Brazil has become an important country in the region for the respiratory care market, which is witnessing increased adoption of non-invasive ventilation devices and portable oxygen concentrators. April 2022: ANVISA, the market regulator for medical devices in Brazil, released a new resolution updating Brazilian Good Manufacturing Practices (BGMP) for medical devices. ANVISA's RDC 665/2022 replaced previous regulations, including RDC 16/2013 and IN 08/2013.

Saudi Arabia Respiratory Care Devices Market

Saudi Arabia’s market is expanding, supported by the increasing prevalence of respiratory conditions such as asthma, sleep apnea, and COPD. The country’s investments in healthcare infrastructure and growing focus on medical innovation drive market growth. The use of advanced apparatus like portable ventilators and oxygen therapy apparatus is growing because of lifestyle disorders and air pollution. Saudi Arabia's strategic plans such as Vision 2030 aim at improving easy accessibility to quality medical healthcare that makes it a high-ranking player in the regional respiratory care device market in the Middle East. Sept 2024, EVA Pharma announced the first phase of its plans to support patients suffering from Asthma and COPD in Saudi Arabia. This marks an important milestone in the group's efforts to meet local needs in the region and demonstrates EVA Pharma's commitment to offering long-term, affordable healthcare solutions.

South Africa Respiratory Care Device Market

South Africa dominates the market for respiratory care devices in Africa, since a majority of the inhabitants are suffering from respiratory diseases including asthma, tuberculosis, and COPD. Urbanization, pollution, and smoking contribute to the increasing adoption of devices such as nebulizers, oxygen concentrators, and non-invasive ventilators, despite several issues in access to healthcare, mainly in urban areas. Government initiatives and collaborations with global medical device companies are making access to advanced respiratory technologies more accessible, and South Africa is becoming a key market in the region.

Respiratory Care Devices Company News

Medtronic

• In February 2024, Medtronic introduced it planned to merge patient tracking and respiratory businesses and go out the ventilator marketplace.
• In October 2022, Medtronic deliberate to cut up its patient monitoring and respiratory intervention agencies from its medical-surgical portfolio. In 2021, they released a pediatric screen that notifies doctors of airway obstructions during ventilation.
• Medtronic released the Puritan Bennett 980 ventilator in 2020. It makes use of superior algorithms to provide personalized ventilation for patients with respiratory failure and offers a number of superior functions for respiration support.

Koninclick-Phillips

• In January 2024, Philips halted sales of breathing care products and sleep therapy devices in the US as a part of a consent decree with the USA Department of Justice.
• In 2021, Philips Healthcare released the Trilogy Evo ventilator, a sophisticated device designed for acute and chronic breathing failure patients. The device gives advanced ventilation modes, superior monitoring skills, and remote connectivity.

General Electric Company

• In 2020, G.E. Healthcare released the Carescape R860 ventilator, a sophisticated device with numerous air flow modes and advanced tracking abilities. It is designed to offer personalized ventilation for significantly sick patients with respiration failure.

Masimo Corporation

• Masimo Corporation bought NantHealth's Connected Care Business in January 2020. Through connectivity, automation, and step forward noninvasive tracking technology, Masimo could be capable of aid hospitals in providing steady care.

ResMed Inc.

• In 2021, ResMed launched its AirSense 11 AutoSet and AirSense 11 AutoSet for Her, two advanced non-stop fantastic airway stress (CPAP) devices that use synthetic intelligence to adjust pressure stages routinely to optimize patient consolation and remedy.
• In 2020, ResMed released the AirFit F30i complete-face masks, a revolutionary tool designed to provide maximum comfort and freedom of movement for patients with sleep apnea. The tool features a unique cushion layout and a number of advanced features for premiere patients consolation.

Getting AB

• In January 2023, Getinge launched the Servo-C, a brand new mechanical ventilator for in depth care devices (ICUs) which could treat adults and youngsters.

Inogen Inc.

• Rove 6 become released in Europe in December 2022, and this 6-setting device has an anticipated carrier existence of 8 years.
• Rove four, a 4-placing device launched inside the U.S. In 2023, received FDA marketplace clearance in December 2022.

Global Respiratory Care Device Market Product Segmentation

Device Type – Market has been covered from 4 viewpoints

• Therapeutic Devices
• Monitoring Devices
• Diagnostic Devices
• Consumables & Accessories

Products 

• Respiratory Consumables
• Nebulizers
• Oxygen Concentrators
• Polysomnography Devices
• Pulse Oximeter
• Mechanical Ventilators
• Spirometers
• Others

Application 

• Chronic Obstructive Pulmonary Disease (COPD)
• Obstructive Sleep Apnea
• Asthma
• Respiratory Distress Syndrome
• Cystic Fibrosis
• Others

End Users 

• Hospitals
• Home Care
• Ambulatory Care

Regional

North America

• United States
• Canada

Latin America

• Mexico
• Brazil

Europe

• United Kingdom
• Germany
• France
• Italy
• Spain
• Netherlands

Asia Pacific

• China
• Japan
•  India
• South Korea
•  Australia

Middle East & Africa

• United Arab Emirates
• South Africa

Rest of the World

All the companies have been studied from 3 points

•    Business Overview
•    Recent Developments
•    Sales Analysis

Company Analysis

• Medtronic Plc
• Koninklijke Philips
• General Electric Company
• Masimo Corporation
• ResMed Inc.
• Becton Dickinson
• Chart Industries Inc.
• Getinge AB
• InogenInc
•  

Report Details: